A Kansas City life sciences company spent $25 million expanding its lab and manufacturing space in Lenexa. Its Lenexa facility is one of three the company uses worldwide to make the raw materials used in vaccine manufacturing and other products.
A Kansas City life sciences company spent $25 million expanding its lab and manufacturing space in Lenexa. Its Lenexa facility is one of three the company uses worldwide to make the raw materials used in vaccine manufacturing and other products.
